Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Jan 14, 2023 2:55pm
111 Views
Post# 35223420

RE:RE:RE:RE:Repurchases so far from NCIB

RE:RE:RE:RE:Repurchases so far from NCIB
Eoj123 wrote: I'm sure glad I sold this about a half a dozen years ago shorly after they sold their priority review voucher and just after their run to $10. It's been a dog since


Well done EOJ.
You don't hold these shares unless you're doing it the way you did it with Paladin.
Only a handful of investors here - accumulating for the long-term.

What did I say ... ~60 investors (give or take) holding 70% of the company.

Tough to say how many own the remaining 30% - but let's call about half of them transient.

And ... the biggest moves that really rock the price won't happen for a while.

You either prepare for it - you wait to join later - or you simply just ignore this one and focus on other things.  Obviously, most of the investing world will just ignore this one.

This will only have a cult following until it doesn't anymore.
When is that ? 
Wouldn't even try to guess.
<< Previous
Bullboard Posts
Next >>